These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 11004692

  • 1. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
    Yakirevich E, Maroun L, Cohen O, Izhak OB, Rennert G, Resnick MB.
    J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
    Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB.
    Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602
    [Abstract] [Full Text] [Related]

  • 3. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
    Yakirevich E, Lefel O, Sova Y, Stein A, Cohen O, Izhak OB, Resnick MB.
    J Pathol; 2002 Jan; 196(1):67-75. PubMed ID: 11748644
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 7. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 8. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC, Barnetson RS, Halliday GM.
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 12. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM, Pandeya N, Cummings MC, Walsh MD, Young JP, Leggett BA, Purdie DM, Jass JR, Radford-Smith GL.
    J Pathol; 2003 Sep 01; 201(1):46-54. PubMed ID: 12950016
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 01; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fas labeling status does not correlate with apoptosis of renal cell carcinoma in vivo.
    Koga F, Arai K, Kamai T, Abe H, Yoshida K.
    Anticancer Res; 2001 Feb 01; 21(5):3193-7. PubMed ID: 11848472
    [Abstract] [Full Text] [Related]

  • 18. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2002 Aug 01; 8(8):2553-62. PubMed ID: 12171883
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
    Hamzaoui A, Ammar J, Graïri H, Hamzaoui K.
    Mediators Inflamm; 2003 Aug 01; 12(4):209-14. PubMed ID: 14514471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.